Back to shop
Epithalon (Epitalon) - 50mg
Longevity

Epithalon (Epitalon) - 50mg

50mg – Lyophilized *MUST BE RECONSTITUTED* Epithalon is a synthetic peptide that has garnered attention for its potential role in anti

$100

50mg – Lyophilized *MUST BE RECONSTITUTED* Epithalon is a synthetic peptide that has garnered attention for its potential role in anti-aging and longevity research. Derived from the naturally occurring epithalamin, Epithalon has been studied for its ability to promote telomere elongation, enhance cellular health, and support the regulation of the body’s circadian rhythms. Research suggests that Epithalon may help improve immune function, delay age-related diseases, and enhance overall vitality.

Important Research Notice

Research use only. Not for human consumption. This product is intended solely for laboratory research and educational applications. It is not designed for use in the diagnosis, treatment, cure, or prevention of any disease or medical condition. By purchasing this product, you acknowledge that this product is intended for research use only and agree to use it in accordance with all applicable laws and regulations.

References

  1. Epithalon (Epitalon) - 50mg - Peptide Center guide
  2. Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising PropertiesInternational journal of molecular sciences, 2025
  3. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activityBiogerontology, 2025
  4. Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitroAging, 2022
  5. The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic RetinopathyStem cell reviews and reports, 2025
  6. Modulating effects of epithalamin and epithalon on the functional morphology of the spleen in old pinealectomized ratsBulletin of experimental biology and medicine, 2001
  7. Studies of the effects of Vilon and Epithalon on gene expression in mouse heart using DNA-microarray technologyBulletin of experimental biology and medicine, 2002